Search

Nurse Questionnaire

This survey is being conducted by the Mucositis and Education Study Groups of the Multinational Association for Supportive Care in Cancer/International Society for Oral Oncology (MASCC/ISOO) and hosted by ManageMucositis.com. We are developing educational materials for patients and professionals to promote awareness and use of evidence-based clinical practice guidelines for managing mucositis. Our goal is to reduce patients’ suffering and improve their quality of life during cancer treatment. The information you provide to us will be very helpful in designing these materials. Thank you in advance for your time and assistance in this important effort.

1. Which group of patients would you expect to have the most severe levels of oral mucositis?

Hematopoietic stem cell transplant.
Standard outpatient chemotherapy.
Radiation therapy for head and neck cancer.
All groups would be expected to have the same levels.

2. Oral mucositis may lead to life-threatening and expensive complications.

Always.
Sometimes.
Rarely.
Never.

3. Oral mucositis is an expected side effect that is usually nothing to worry about.

Always.
Sometimes.
Rarely.
Never.

4. Oral mucositis can be a dose-limiting side effect that may prevent delivery of optimal cancer treatment.

Always.
Sometimes.
Rarely.
Never.

5. What is your opinion on whether cancer patients should see a dentist prior to starting their cancer treatment?

It doesn’t matter if they see a dentist.
Patients should be able to choose.
It definitely makes a difference.
It depends on the treatment regimen or protocol.

6. How often should mouth assessment be done during muco-toxic cancer treatment?

Once a day.
After each meal.
Only when there are problems such as dryness or soreness.
Assessment is not that important.

7. Who provides information about mucositis to patients where you practice?

The nurse.
The oncologist.
Family and/or friends.
No one.

8. The Multinational Association for Supportive Care in Cancer (MASCC) recently published evidence-based clinical practice guidelines for managing mucositis. Which of the following best describes your experience with these guidelines?

I have never heard of the guidelines.
I have heard of the guidelines, but have not tried to use them.
I have considered using these guidelines.
I have used these guidelines in my practice.

9. If you have tried to use the MASCC guidelines in your practice, which statement best describes your experience?

The guidelines were clear, relevant, and useful.
Only certain parts of the guidelines were useful.
Colleagues were not receptive to the guidelines.
My institution was not supportive.
N/A

10. What is your opinion about having patient educational materials based on the MASCC guidelines?

I feel strongly that they are needed and would use them.
I might use them if a patient had a problem with mucositis.
There are already enough patient education materials on mucositis.
I don’t feel strongly one way or the other.
N/A